Daiichi Sankyo to sell API plant at Akita to Japanese firm
06:49 AM | August 8, 2014 | Deepti Ramesh
Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer Alfresa Pharma (Osaka) to sell the active pharmaceutical ingredient (API) plant...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.